Plasma gelsolin levels and 1-year mortality after first-ever ischemic stroke.

J Crit Care

Department of Laboratory Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, PR China.

Published: December 2011

Purpose: Plasma gelsolin depletion has been associated with poor outcome of critically ill patients. We sought to investigate change in plasma gelsolin level after ischemic stroke and to evaluate its relation with disease outcome.

Materials And Methods: Fifty healthy controls and 172 patients with first-ever ischemic stroke were included. Plasma samples were obtained within 24 hours from stroke onset. Its concentration was measured by enzyme-linked immunosorbent assay.

Results: Plasma gelsolin level in stroke patients was significantly decreased compared with healthy controls. A multivariate analysis showed that plasma gelsolin level was an independent predictor for 1-year mortality (odds ratio, 0.945; 95% confidence interval [CI], 0.918-0.974; P = .0002) and negatively associated with National Institutes of Health Stroke Scale (NIHSS) score (t = -4.802, P < .001) and plasma C-reactive protein level (t = -4.197, P < .001). A receiver operating characteristic curve identified that a baseline plasma gelsolin level less than 52.0 mg/L predicted 1-year mortality of patients with 73.0% sensitivity and 65.2% specificity (area under curve [AUC], 0.738; 95% CI, 0.666-0.802). The predictive value of the gelsolin concentration was similar to that of NIHSS score (AUC, 0.742; 95% CI, 0.670-0.806; P = .940). Gelsolin improved the AUC of NIHSS score to 0.814 (95% CI, 0.747-0.869; P = .032).

Conclusions: Plasma gelsolin level is a useful, complementary tool to predict mortality after ischemic stroke.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrc.2011.02.007DOI Listing

Publication Analysis

Top Keywords

plasma gelsolin
28
gelsolin level
20
ischemic stroke
16
1-year mortality
12
nihss score
12
plasma
9
first-ever ischemic
8
gelsolin
8
healthy controls
8
stroke
7

Similar Publications

Article Synopsis
  • The study aimed to assess how human subjects react to elevated pressures of helium and nitrogen, focusing on inflammatory and oxidative stress responses.
  • Both gases activated neutrophils and led to slight increases in inflammatory markers and urinary IL-6, alongside a decrease in plasma gelsolin, indicating an inflammatory response.
  • The results suggest that typical diving gas exposure can trigger inflammation, which might contribute to decompression sickness, while the mixed oxidative stress responses imply complex interactions within the body's systems.
View Article and Find Full Text PDF
Article Synopsis
  • Research examines how tunnel workers experience high pressure exposure compared to SCUBA divers, focusing on inflammation linked to decompression sickness (DCS).
  • Despite longer high-pressure exposure in tunnel workers (4.1-4.9 hours) versus shorter exposure for divers (0.61 hours), blood analysis showed similar increases in blood microparticles and interleukin levels for both groups.
  • Neutrophil counts and activation were significantly higher in tunnel workers, indicating that while microparticle levels stabilize quickly, neutrophil activation requires more time under high pressure conditions.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the role of plasma gelsolin (pGSN), a protein that breaks down actin filaments, in inflammatory and neurodegenerative diseases, particularly in a mouse model of decompression sickness (DCS).
  • - Mice exposed to high pressure showed a significant decrease in pGSN levels and increased inflammatory microparticles (MPs), which led to neuroinflammation and cognitive/motor function impairments lasting over 12 days.
  • - Administering recombinant human plasma gelsolin (rhu-pGSN) effectively reduced inflammation, restored synaptic protein levels, and improved neurological function, suggesting that rhu-pGSN could be a potential treatment for DCS.
View Article and Find Full Text PDF

Milk Fat Globules: 2024 Updates.

Newborn (Clarksville)

March 2024

Global Newborn Society, Clarksville Maryland, United States of America.

Article Synopsis
  • * MFGs feature a unique structure with a lipid core and a membrane rich in bioactive components that aid in energy release and support immune health in developing gastrointestinal tracts.
  • * Research suggests MFGs can be enhanced to address specific nutritional deficiencies while also having potential therapeutic benefits for neurodevelopment and defense against infections.
View Article and Find Full Text PDF

Real-time analysis of the biomolecular interaction between gelsolin and Aβ monomer and its implication for Alzheimer's disease.

Talanta

January 2025

State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China. Electronic address:

Biomolecular interaction acts a pivotal part in understanding the mechanisms underlying the development of Alzheimer's disease (AD). Herein, we built a biosensing platform to explore the interaction between gelsolin (GSN) and different β-amyloid protein 1-42 (Aβ) species, including Aβ monomer (m-Aβ), Aβ oligomers with both low and high levels of aggregation (LLo-Aβ and HLo-Aβ) via dual polarization interferometry (DPI). Real-time molecular interaction process and kinetic analysis showed that m-Aβ had the strongest affinity and specificity with GSN compared with LLo-Aβ and HLo-Aβ.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!